Peter Jan Sture Ström
Directeur/Bestuurslid bij WNTRESEARCH AB
Oorsprong van het eerstegraads netwerk van Peter Jan Sture Ström
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Other | 21 | |
Stockholm Corporate Finance AB
 Stockholm Corporate Finance AB Investment ManagersFinance Stockholm Corporate Finance AB operates as an independent and privately-owned financial company, which offers financial advisory by taking transaction initiatives, acting in an advisory capacity, and assisting with transaction process implementation. The firm works closely with owners, board members, and management in listed and privately held companies. The company was founded by Harry Nudel and Gunnar Wedfelt in 2004 and is headquartered in Stockholm, Sweden.
9
| Subsidiary | Investment Managers | 9 |
Wntresearch Incentive AB
3
| Private Company | 3 | |
DentoSystem Scandinavia AB
 DentoSystem Scandinavia AB Medical/Nursing ServicesHealth Services DentoSystem Scandinavia AB engages in the provision of dental care services. It develops artificial teeth, dentures, and dental plates. The company was founded by Sven Fredrik Lindskog and Leif Blomlöf in August 9, 1995 and is headquartered in Stockholm, Sweden.
1
| Private Company | Medical/Nursing Services | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Peter Jan Sture Ström via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Swedish Export Credit Corp.
 Swedish Export Credit Corp. Finance/Rental/LeasingFinance Swedish Export Credit Corp. engages in the provision of financial solutions on commercial terms by granting export credits and direct lending to exporters. It also administers the state-supported export credit system, CIRR. It offers export credits, lending, structured financing, project financing, leasing, capital market products, and financial advisory services. It also offers its solutions to corporations, the public sector, financial institutions as well as domestic and international capital investors. The company was founded in 1962 and is headquartered in Stockholm, Sweden. | Finance/Rental/Leasing | Director/Board Member | |
| PROBI AB | Biotechnology | Director/Board Member Director/Board Member | |
| ORION OYJ | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
| ALLIGATOR BIOSCIENCE AB | Biotechnology | Chief Executive Officer | |
| Stockholm School of Economics | College/University | Corporate Officer/Principal Masters Business Admin | |
| University of Uppsala | College/University | Graduate Degree Masters Business Admin Graduate Degree | |
| INDEX PHARMACEUTICALS HOLDING AB | Pharmaceuticals: Major | Chief Operating Officer | |
| University of Stockholm | College/University | Masters Business Admin Graduate Degree Undergraduate Degree | |
| University of Lund | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Masters Business Admin Graduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| VIVESTO AB | Pharmaceuticals: Generic | Chief Executive Officer | |
| NIMUTAN AB (PUBL) | Household/Personal Care | Director/Board Member | |
| University of Gothenburg | College/University | Corporate Officer/Principal Masters Business Admin Graduate Degree Doctorate Degree | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Teva GmbH
 Teva GmbH Medical DistributorsDistribution Services Part of Teva Pharmaceutical Industries Ltd., Teva GmbH is a German company that aims to provide high-quality medicines to improve the quality of life of patients. The company is based in Ulm, Germany. The CEOs are Thomas Andreas Schlenker, Andreas Burkhardt, Christoph Stoller. The company was founded in 2011. | Medical Distributors | Corporate Officer/Principal | |
Helsingborgshem AB
 Helsingborgshem AB Real Estate DevelopmentFinance Helsingborgshem AB operates as a regional housing company that owns and operates apartments and commercial properties. It offers ordinary apartments of various sizes and designs, townhouses, student rooms, senior housing, and collective housing. The company was founded in 1946 and is headquartered in Helsingborg, Sweden. | Real Estate Development | Director of Finance/CFO | |
Telge Bostäder AB
 Telge Bostäder AB Real Estate DevelopmentFinance Telge Bostäder AB is the Swedish largest housing company in Södertälje, SE, founded in 1948 and ultimately controlled by the City of Södertälje (Sweden). The company owns and manages approximately 10,000 apartments and follows a self-cost principle for water and sewage. Telge Bostäder offers various services to its tenants, including waste management, where food waste is converted into biogas and bio-fertilizer. The company also provides support to customers with high electricity prices. Additionally, Telge Bostäder promotes upcycling to save the earth's resources. The CEO is Pontus Werlinder. | Real Estate Development | Director of Finance/CFO | |
| OxyPharma AB | Chief Executive Officer | ||
TikoMed AB
 TikoMed AB Pharmaceuticals: MajorHealth Technology TikoMed AB is a Swedish pharmaceutical company that develops pharmaceutical products. The private company is based in Viken, Sweden. The company was founded by Adam Bruce, Lars Bruce. Anders Kristensson has been the CEO of the company since 2018. | Pharmaceuticals: Major | Director/Board Member | |
| Orion Diagnostica AB | Director/Board Member | ||
| The University of North Carolina at Charlotte | College/University | Corporate Officer/Principal | |
InDex Diagnostics AB
 InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Pharmaceuticals: Major | Director/Board Member | |
| XINTELA AB | Biotechnology | Chief Tech/Sci/R&D Officer | |
Atlas Therapeutics AB
 Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013. | Pharmaceuticals: Major | Director/Board Member | |
| New York University School of Law | College/University | Graduate Degree | |
| IDOGEN AB (PUBL) | Biotechnology | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| Fermion Ltd. | Director/Board Member | ||
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden. | Pharmaceuticals: Major | Chief Operating Officer | |
| International Women's Forum Sweden | Chairman | ||
| REDWOOD PHARMA AB | Pharmaceuticals: Major | Chairman | |
| EVAXION BIOTECH A/S | Biotechnology | Chief Executive Officer | |
| LIPUM AB | Biotechnology | Chairman | |
| Ub-Consulting AB | Chief Executive Officer | ||
InDex Pharmaceuticals AB
 InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Operating Officer | |
| STAYBLE THERAPEUTICS AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
| A Bioscience Incentive AB | Chairman | ||
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| ANNEXIN PHARMACEUTICALS AB | Pharmaceuticals: Major | Director/Board Member | |
Innovativa Mindre Life Science
 Innovativa Mindre Life Science Miscellaneous Commercial ServicesCommercial Services Innovativa Mindre Life Science is an association of small and medium-sized Swedish companies that conduct research in the field of pharmaceuticals and medical technology. | Miscellaneous Commercial Services | Director/Board Member | |
Targinta AB
 Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Biotechnology | Chief Executive Officer | |
| Synartro AB | Chief Tech/Sci/R&D Officer | ||
Mindforce Game Lab AB
 Mindforce Game Lab AB Packaged SoftwareTechnology Services Mindforce Game Lab AB creates games for people with medical conditions, called Playtients™, to help them develop healthy habits. The games are designed to act as companions on the journey to better health and are created by bringing together leading life scientists and top game designers. The CEO of the Swedish company is Anders Rabbe. | Packaged Software | Chief Executive Officer | |
| Human Search | Chairman | ||
Epicyt Pharma AB
 Epicyt Pharma AB Pharmaceuticals: MajorHealth Technology Epicyt Pharma AB is a Swedish pharmaceutical research company that was founded in 2016 by Ville Wallenius and Lars Fändriks. The company is based in Mölndal, Sweden. Epicyt Pharma develops the drug candidate BAFA. | Pharmaceuticals: Major | Director/Board Member | |
| ALZINOVA AB | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
| Zweden | 41 |
| Verenigde Staten | 6 |
| Finland | 2 |
| Duitsland | 2 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 9 |
| Finance | 4 |
| Commercial Services | 3 |
| Consumer Non-Durables | 2 |
Operationeel
| Director/Board Member | 99 |
| Corporate Officer/Principal | 47 |
| Chief Executive Officer | 23 |
| Chairman | 21 |
| Chief Operating Officer | 14 |
Sterkste connecties
| Insiders | |
|---|---|
| Kjell Sture Stenberg | 29 |
| Dennis Bang Henriksen | 19 |
| Marie Reinius | 18 |
| Ulf Björklund | 14 |
| Ulla Hald Buhl | 12 |
| Jan Nilsson | 12 |
| Per-Ola Forsberg | 11 |
| Christer Nordstedt | 10 |
| Per Norlén | 9 |
| Anders Rabbe | 9 |
| Ulf Fredrik Werner Risberg | 9 |
| Pernilla Sandwall | 8 |
| Daniel Hofmann | 7 |
| Tommy Evert Andersson | 6 |
| Martin Olovsson | 6 |
- Beurs
- Insiders
- Peter Jan Sture Ström
- Bedrijfsconnecties
